De Leo S - Search Results

1

Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization.

Benaglia L, Busnelli A, Somigliana E, Leonardi M, Vannucchi G, De Leo S, Fugazzola L, Ragni G, Fedele L. Benaglia L, et al. Among authors: de leo s. Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:53-7. doi: 10.1016/j.ejogrb.2013.11.003. Epub 2013 Nov 9. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24332278

2

Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes.

Vannucchi G, Covelli D, Perrino M, De Leo S, Fugazzola L. Vannucchi G, et al. Among authors: de leo s. Endocrine. 2014 Nov;47(2):648-51. doi: 10.1007/s12020-014-0215-0. Epub 2014 Mar 8. Endocrine. 2014. PMID: 24610207

3

Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer.

Vannucchi G, De Leo S, Perrino M, Rossi S, Tosi D, Cirello V, Colombo C, Bulfamante G, Vicentini L, Fugazzola L. Vannucchi G, et al. Among authors: de leo s. Eur J Endocrinol. 2015 Jul;173(1):29-36. doi: 10.1530/EJE-15-0054. Epub 2015 Apr 10. Eur J Endocrinol. 2015. PMID: 25862786

4

Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.

Colombo C, De Leo S, Di Stefano M, Vannucchi G, Persani L, Fugazzola L. Colombo C, et al. Among authors: de leo s. J Clin Endocrinol Metab. 2019 Mar 1;104(3):779-784. doi: 10.1210/jc.2018-01836. J Clin Endocrinol Metab. 2019. PMID: 30383218 Free PMC article.

5

The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association.

Fugazzola L, De Leo S, Perrino M. Fugazzola L, et al. Among authors: de leo s. Thyroid Res. 2013 Mar 14;6 Suppl 1(Suppl 1):S8. doi: 10.1186/1756-6614-6-S1-S8. Epub 2013 Mar 14. Thyroid Res. 2013. PMID: 23514012 Free PMC article.

6

Recent advances in the management of anaplastic thyroid cancer.

De Leo S, Trevisan M, Fugazzola L. De Leo S, et al. Thyroid Res. 2020 Nov 24;13(1):17. doi: 10.1186/s13044-020-00091-w. Thyroid Res. 2020. PMID: 33292371 Free PMC article. Review.

7

Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer.

Tresoldi AS, Sburlati LF, Rodari M, Schinkelshoek MS, Perrino M, De Leo S, Montefusco L, Colombo P, Arosio M, Lania AGA, Fugazzola L, Chiti A. Tresoldi AS, et al. Among authors: de leo s. J Endocrinol Invest. 2014 Aug;37(8):709-714. doi: 10.1007/s40618-014-0088-3. Epub 2014 May 21. J Endocrinol Invest. 2014. PMID: 24844565

8

Fetal cell microchimerism in papillary thyroid cancer: A role in the outcome of the disease.

Cirello V, Colombo C, Perrino M, De Leo S, Muzza M, Maffini MA, Fugazzola L. Cirello V, et al. Among authors: de leo s. Int J Cancer. 2015 Dec 15;137(12):2989-93. doi: 10.1002/ijc.29653. Epub 2015 Jul 2. Int J Cancer. 2015. PMID: 26105768

9

Body Composition and Leptin/Ghrelin Levels during Lenvatinib for Thyroid Cancer.

De Leo S, Colombo C, Di Stefano M, Dubini A, Cozzi S, Persani L, Fugazzola L. De Leo S, et al. Eur Thyroid J. 2020 Jan;9(1):1-10. doi: 10.1159/000504048. Epub 2019 Dec 17. Eur Thyroid J. 2020. PMID: 32071896 Free PMC article.

10

Lenvatinib as first-line treatment for advanced thyroid cancer: long progression-free survival.

De Leo S, Di Stefano M, Persani L, Fugazzola L, Colombo C. De Leo S, et al. Endocrine. 2021 May;72(2):462-469. doi: 10.1007/s12020-020-02477-0. Epub 2020 Sep 3. Endocrine. 2021. PMID: 32885329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters